ZI

Zenflow, Inc.

www.zenflow.com link_icon

Zenflow, Inc. Market Research Report



Company Overview



  • Name: Zenflow, Inc.

  • Mission of the Company: Zenflow was founded with a focus on patient comfort and aims to develop safer and more effective treatments for an enlarged prostate, providing freedom from BPH (benign prostatic hyperplasia) with a patient-friendly approach.

  • Founded: Evolved from the Stanford Byers Center for Biodesign.

  • Founder(s): Shreya Mehta, a technical leader in medical devices.

  • Key People:

  • Shreya Mehta - CEO & Founder

  • Ronald Jabba - COO

  • John Beck - CFO

  • Sierra Yearsley - SVP Clinical & Regulatory

  • Jamey Nielsen - VP R&D

  • Mike Welch - VP Market Development

  • Headquarters: 395 Oyster Point Blvd., Suite 501, South San Francisco, CA 94080, USA.

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Known For: Zenflow is known for developing innovative treatments for BPH with a focus on patient comfort and effectiveness.


Products



Zenflow Spring System



  • Product Description: The Spring System is a minimally invasive treatment designed to address the symptoms of an enlarged prostate (BPH) by gently propping open the urethral opening to restore flow.


Key Features:


  • Patient Comfort: No burning, cutting, or piercing, making it an ultra-precise and comfortable patient experience.

  • Material & Design: Made from a super-elastic shape-memory material, custom-fit for long-lasting relief.

  • Procedure: Delivered through a low-profile flexible scope.

  • Recovery: Fast recovery, most patients can recover within hours, demonstrating lasting symptom relief.

  • Setting: Can be performed in an office or OR setting.


Recent Developments



  • Innovations & Clinical Evaluations:

  • The Zenflow procedure is currently being clinically evaluated for optimization as a solution for BPH with promising initial trials demonstrating lasting symptom relief.


  • Product Launches:

  • No specific new product launches were mentioned beyond the ongoing focus on the Spring System.


  • Product Enhancements:

  • Recent trials and clinical studies continue to showcase the effectiveness and patient tolerance of the Spring System, with durability results extending to at least two years.


  • Partnerships:

  • Collaboration with top urologists globally in the rigorous clinical trial program.


  • Noteworthy Events:

  • May 1, 2023: Zenflow Spring System was featured at both AUA (American Urological Association) and EAU (European Association of Urology) meetings.

  • October 4, 2021: Launch of a pivotal clinical trial for the Spring Treatment for enlarged prostate symptoms.


Additional Insights



  • Leadership & Recognition:

  • Shreya Mehta, listed as Healthtech Leader of the Month.

  • Featured in Forbes Article: 50 Women-Led Startups that are Crushing Tech.


  • Boards and Recognition:

  • Zenflow recognized as MedTech Innovator in 2015 and Rosenman Innovators in 2017.


  • Advisory and Governance:

  • The Board of Directors includes seasoned professionals like Andrew Cleeland, CEO of Fogarty Institute for Innovation, and Susan Stimson, an executive board director with extensive experience in healthcare.


This report is compiled with the most comprehensive data available as of now. Further details and updates will follow as new information arises.